armstadt, March 30, 2016 – Compliance behavior is also becoming increasingly important when it comes to exchanging sensitive data with customers and suppliers. Therefore, PROSTEP AG is now making additional options that help ensure that corporate guidelines are observed available in version 8.2 of its OpenDXM GlobalX data exchange solution. The newly introduced "four-eye principle" makes it possible to define data classes that cannot be sent before approval has been given by one or more persons.
In addition to compliance-related enhancements, OpenDXM GlobalX 8.2 also offers new automatic functions for reducing the time and effort needed for reporting tasks. Users who have the appropriate permission can save table filters as serial reports, which are then uploaded to a defined WebSpace. When using the Windows Explorer integration, files in OpenDXM GlobalX WebSpaces can now also be deleted. In addition, PROSTEP has significantly enhanced the authorization concept to allow certain administrator privileges/functions to be assigned more specifically. A total of more than 50 new and useful functions have been implemented in OpenDXM GlobalX 8.2.
As always, PROSTEP has made the new version of OpenDXM GlobalX available to its customers in the download portal, securely and in encrypted form, via the data exchange solution.
About PROSTEP AG
PROSTEP AG is recognized as the leading PLM integration specialist in the area of product data integration. The company offers customers from the aerospace, automotive, shipbuilding and mechanical engineering industries – including the Airbus Group, BMW, Volkswagen, Daimler – integration solutions for CAD, PDM and supplier communication, thus making e-engineering a reality.
The PROSTEP Group has a current headcount of more than 250 in Germany and the USA. In addition to its headquarters in Darmstadt, PROSTEP also maintains branch offices in Berlin, Hamburg, Hanover, Cologne, Munich, Stuttgart, and Wolfsburg, as well as in Birmingham, Michigan (USA).
All press releases can be downloaded on our website: www.prostep.com/en/mn/presse/